Published in Am J Psychiatry on January 01, 1970
Some evidence for the involvement of adrenergic sites in the memory trace. Proc Natl Acad Sci U S A (1970) 1.04
Acute treatment with antidepressant drugs selectively increases the expression of c-fos in the rat brain. J Psychiatry Neurosci (1995) 0.94
Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review. J Psychiatry Neurosci (1992) 0.91
The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry (1965) 5.09
Biogenic amines and emotion. Science (1967) 3.49
Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite. Biochem Pharmacol (1968) 1.86
The effects of psychoactive drugs on norepinephrine-3-H metabolism in brain. Biochem Pharmacol (1967) 1.54
Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine? Harv Rev Psychiatry (1999) 1.21
The catecholamine hypothesis of affective disorders: a review of supporting evidence. 1965. J Neuropsychiatry Clin Neurosci (1995) 1.14
The current status of biological criteria for classifying the depressive disorders and predicting responses to treatment. Psychopharmacol Bull (1974) 1.06
Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings. Am J Psychiatry (1973) 0.99
Diurnal variation of plasma cortisol and homovanillic acid in healthy subjects. Psychoneuroendocrinology (1996) 0.97
Normetanephrine excretion and affective state in depressed patients treated with imipramine. Am J Psychiatry (1966) 0.97
Amphetamine withdrawal: affective state, sleep patterns, and MHPG excretion. Am J Psychiatry (1972) 0.96
The effects of delta-9-tetrahydrocannabinol on the metabolism of norepinephrine in rat brain. Psychopharmacologia (1971) 0.93
Amphetamine withdrawal: effects on threshold of intracranial reinforcement. Psychopharmacology (Berl) (1981) 0.92
Norepinephrine metabolism and drugs used in the affective disorders: a possible mechanism of action. Am J Psychiatry (1967) 0.91
Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis. Neurology (1988) 0.89
Neuropharmacology of the affective disorders. Annu Rev Pharmacol (1973) 0.89
Amitriptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study. J Clin Psychopharmacol (1985) 0.89
Desynchronized sleep and MHPG excretion: an inverse correlation. Brain Res (1973) 0.88
Biogenic amines and affective disorders. Annu Rev Med (1974) 0.87
Alterations in brain norepinephrine metabolism induced by environmental stimuli previously paired with inescapable shock. Science (1980) 0.86
Toward a biochemical classification of depressive disorders--VIII. Platelet monoamine oxidase activity in subtypes of depressions. J Psychiatr Res (1985) 0.85
Effects of 6-hydroxydopamine on sleep in the rat. Nature (1971) 0.85
Should clozapine be a first-line treatment for schizophrenia? The rationale for a double-blind clinical trial in first-episode patients. Harv Rev Psychiatry (1997) 0.85
Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions. Arch Gen Psychiatry (1978) 0.84
The effects of tranylcypromine isomers on norepinephrine-H3 metabolism in rat brain. Psychopharmacology (Berl) (1980) 0.83
Alpha-methylparatyrosine and sleep in the rat. Psychopharmacologia (1971) 0.83
Catecholamine metabolism in affective disorders. I. Normetanephrine and VMA excretion in depressed patients treated with imipramine. J Psychiatr Res (1965) 0.82
Catecholamine metabolism in affective disorders. IV. Preliminary studies of norepinephrine metabolism in depressed patients treated with amitriptyline. J Psychiatr Res (1972) 0.82
Amphetamine withdrawal: depression and M.H.P.G. excretion. Lancet (1971) 0.82
Alterations in brain norepinephrine metabolism and behavior induced by environmental stimuli previously paired with inescapable shock. Behav Brain Res (1981) 0.81
Effects of tricyclic antidepressants on the uptake and mabolism of intracisternally administered norepinephrine-H3 in rat brain. J Psychiatr Res (1969) 0.81
Clinical utility of tricyclic antidepressant blood levels: a case report. Am J Psychiatry (1979) 0.81
Late feedback effects of hypothalamic-pituitary-adrenal axis hormones in healthy subjects. Psychoneuroendocrinology (1998) 0.81
Norepinephrine turnover and metabolism in rat brain after long-term administration of imipramine. Science (1970) 0.81
Norepinephrine metabolism in the rat brain following acute and chronic administration of thyrotropin releasing hormone. Psychopharmacologia (1974) 0.81
Abnormal flash visual evoked response in melancholia: a replication study. Biol Psychiatry (1992) 0.81
Hypothalamic-pituitary-adrenal axis activity and 1-year outcome in depression. Biol Psychiatry (1993) 0.81
The effects of pentobarbital on the fate of intracisternally administered norepinephrine-H3. J Pharmacol Exp Ther (1967) 0.80
Changes in norepinephrine output following light therapy for fall/winter seasonal depression. Biol Psychiatry (1992) 0.80
Biochemical criteria for classifying depressive disorders and predicting responses to pharmacotherapy: preliminary findings from studies of norepinephrine metabolism. Contributions to biochemistry. Pharmakopsychiatr Neuropsychopharmakol (1974) 0.80
The catecholamine hypothesis of affective disorders. A review of supporting evidence. Int J Psychiatry (1967) 0.80
Effects of psychoactive drugs on the metabolism of intracisternally administered serotonin in rat brain. Biochem Pharmacol (1969) 0.79
Signal transduction by platelet adenylate cyclase: alterations in depressed patients may reflect impairment in the coordinated integration of cellular signals (coincidence detection). Biol Psychiatry (1998) 0.79
The effects of lithium ion on H3-norepinephrine metabolism in brain. Life Sci (1966) 0.79
Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients. Am J Psychiatry (1976) 0.79
Rapid antidepressant response to alprazolam in depressed patients with high catecholamine output and heterologous desensitization of platelet adenylate cyclase. Biol Psychiatry (1988) 0.78
Changes in norepinephrine turnover in rat brain during chronic administration of imipramine and protriptyline: a possible explanation for the delay in onset of clinical antidepressant effects. Am J Psychiatry (1971) 0.78
Catecholamine metabolism in affective disorders. 3. MHPG and other catecholamine metabolites in patients treated with lithium carbonate. J Psychiatr Res (1970) 0.78
Determination of urinary normetanephrine and metanephrine by radial-compression liquid chromatography and electrochemical detection. Clin Chem (1983) 0.77
Platelet MAO activity and the dexamethasone suppression test in depressed patients. Am J Psychiatry (1983) 0.77
Cortisol feedback effects on plasma corticotropin levels in healthy subjects. Psychoneuroendocrinology (1997) 0.77
Toward a biochemical classification of depressive disorders. X. Urinary catecholamines, their metabolites, and D-type scores in subgroups of depressive disorders. Arch Gen Psychiatry (1989) 0.77
Amphetamine withdrawal: effects on brain levels of MHPG-SO4 in the rat. Commun Psychopharmacol (1979) 0.77
M.H.P.G. excretion and clinical classification in depressive disorders. Lancet (1973) 0.77
Toward a biochemical classification of depressive disorders, V: Heterogeneity of unipolar depressions. Am J Psychiatry (1982) 0.77
Clozapine response and plasma catecholamines and their metabolites. Psychiatry Res (1993) 0.77
Norepinephrine content of various rat organs after chronic administration of desmethylimipramine. Arch Int Pharmacodyn Ther (1975) 0.77
Catecholamines in affective disorders. Psychopharmacol Bull (1975) 0.76
Focal cerebral perfusion defects demonstrated by 99mTc-hexamethylpropyleneamine oxime SPECT in elderly depressed patients. Psychiatry Res (1996) 0.76
Catecholamine metabolism during heroin use. Am J Psychiatry (1977) 0.76
Toward a biochemical classification of depressive disorders. III: Pretreatment urinary MHPG levels as predictors of response to treatment with maprotiline. Psychopharmacology (Berl) (1981) 0.76
Hypothalamic-pituitary-adrenal axis effects on plasma homovanillic acid in man. Biol Psychiatry (1999) 0.76
Urinary MHPG and clinical symptoms in patients with unipolar depression. Psychiatry Res (1994) 0.76
Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders. Biol Psychiatry (1978) 0.76
Toward a biochemical classification of depressive disorders IV: Pretreatment urinary MHPG levels as predictors of antidepressant response to imipramine. Commun Psychopharmacol (1980) 0.76
Pretreatment urinary MHPG levels as predictors of antidepressant responses to alprazolam. Am J Psychiatry (1985) 0.76
Sodium inhibits both adenylate cyclase and high-affinity 3H-labeled p-aminoclonidine binding to alpha 2-adrenergic receptors in purified human platelet membranes. Mol Pharmacol (1982) 0.76
Abnormal visual evoked response in melancholia. Biol Psychiatry (1989) 0.75
Neuropsychopharmacology and the affective disorders (second of three parts). N Engl J Med (1969) 0.75
The effects of heroin on catecholamine metabolism in man. Natl Inst Drug Abuse Res Monogr Ser (1975) 0.75
Platelet monoamine oxidase activity in subgroups of schizophrenic disorders. Schizophr Bull (1980) 0.75
Psychotic and nonpsychotic depressions: II. Platelet MAO activity, plasma catecholamines, cortisol, and specific symptoms. Psychiatry Res (1987) 0.75
Neuropsychopharmacology and the affective disorders. (First of three parts). N Engl J Med (1969) 0.75
Noradrenergic activity during the transition from depression to mania. Lancet (1971) 0.75
The effects of acute and chronic administration of morphine on norepinephrine turnover in rat brain regions. Biochem Pharmacol (1977) 0.75
Proceedings: Norepinephrine metabolism in subtypes of depressive disorders. Psychopharmacol Bull (1974) 0.75
Effects of acute and chronic administration of desmethylimipramine on the content of norepinephrine and other monoamines in the rat brain. Biochem Pharmacol (1973) 0.75
MHPG excretion in depressive disorders: relation to clinical subtypes and desynchronized sleep. Science (1973) 0.75
Properties of catechol-O-methyl transferase in soluble and particulate preparations from rat red blood cells. Biochem Pharmacol (1976) 0.75
Affective disorders and norepinephrine pharmacology. Int Psychiatry Clin (1969) 0.75
Norepinephrine pools in rat brain: differences in turnover rates and pathways of metabolism. Science (1971) 0.75
The effects of lthium salts on the turnover and metabolism of norepinephrine in rat brain. Psychopharmacologia (1969) 0.75
Haloperidol response and plasma catecholamines and their metabolites. Schizophr Res (1993) 0.75
Neuropsychopharmacology and the affective disorders. (Third of three parts) N Engl J Med (1969) 0.75
Norepinephrine metabolism after short- and long-term administration of tricyclic antidepressant drugs and electroconvulsive shock. Adv Biochem Psychopharmacol (1975) 0.75
Platelet monoamine oxidase activity and deficit syndrome schizophrenia. Psychiatry Res (1995) 0.75
Turnover and metabolism of norepinephrine in rat brain after 72 hours on a D-deprivation island. Psychopharmacologia (1972) 0.75
Effects of short-and long-term administration of tricyclic antidepressants and lithium on norepinephrine turnover in brain. Pharmakopsychiatr Neuropsychopharmakol (1976) 0.75
Antidepressant drugs. Science (1966) 0.75
The effects of acute and chronic morphine administration on the levels of 3-methoxy-4-hydroxphenylglycol sulfate in rat brain. Res Commun Chem Pathol Pharmacol (1975) 0.75
Proceedings: Comparative properties of soluble and particulate catechol-O-methyl transferase from rat red blood cell: preliminary observations. Psychopharmacol Bull (1974) 0.75
The effects of acute and chronic administration of tricyclic antidepressants on MHPG-SO4 in rat brain. Commun Psychopharmacol (1977) 0.75
Comparative properties of soluble and particulate catechol-O-methyl transferases from rat red blood cells: preliminary observations. Adv Biochem Psychopharmacol (1974) 0.75
The effects of lithium on norepinephrine turnover and metabolism: basic and clinical studies. J Nerv Ment Dis (1974) 0.75
Acute and delayed effects of corticotropin-releasing hormone on dopamine activity in man. Biol Psychiatry (1994) 0.75
Catecholamine metabolism in affective disorders. II. Norepinephrine, normetanephrine, epinephrine, metanephrine, and VMA excretion in hypomanic patients. Arch Gen Psychiatry (1969) 0.75
Learned helplessness and urinary MHPG levels in unipolar depression. Am J Psychiatry (1992) 0.75
MHPG as a predictor of antidepressant response to imipramine and maprotiline. Am J Psychiatry (1980) 0.75
Neuropharmacological studies of mood disorders. Proc Annu Meet Am Psychopathol Assoc (1972) 0.75
Psychopharmacology of biogenic amines in depressions. Psychopharmacol Bull (1975) 0.75